LON:TRX Tissue Regenix Group (TRX) Share Price, News & Analysis GBX 0.07 0.00 (0.00%) As of 01/6/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About Tissue Regenix Group Stock (LON:TRX) Get Tissue Regenix Group alerts:Sign Up Key Stats Today's Range 0.07▼ 0.0750-Day Range 0.07▼ 0.0752-Week Range 4.77▼ 66VolumeN/AAverage Volume169,613 shsMarket Capitalization£51.65 thousandP/E RatioN/ADividend Yield4.12%Price TargetN/AConsensus RatingN/A Company Overview Tissue Regenix is a leading medical device company in regenerative medicine. The Company's patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient's body that can be used to repair diseased or damaged body structures. Current applications address many crucial clinical needs in sports medicine, foot and ankle injuries, and wound care. In August 2017, Tissue Regenix acquired CellRight Technologies®. This biotech company specialises in regenerative medicine and is dedicated to developing high-quality, innovative tissue scaffolds to enhance healing opportunities in defects created by trauma and disease. CellRight's human tissue products may be used in spine, trauma, general orthopaedic, dental and ophthalmological surgical procedures. Read More Receive TRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tissue Regenix Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TRX Stock News HeadlinesTissue Regenix Group PLCApril 22, 2026 | marketwatch.comCellRight Tech: Private Equity Funding SecuredJanuary 8, 2026 | finance.yahoo.comSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. Elon believes what Michael Robinson calls 'Project Unlimited' could unlock $100 trillion in potential growth. One little-known company sits at the center of it all, and most investors have no idea it exists. Position yourself before this company potentially hits the front page.June 23 at 1:00 AM | Weiss Ratings (Ad)CellRight Technologies, LLC Announces Update and Senior Leadership ChangesOctober 21, 2025 | finance.yahoo.comTissue Regenix Group PLC (LSE:TRX) Full Year 2024 Earnings Call Highlights: Record Profit and ...July 3, 2025 | finance.yahoo.comTissue Regenix Scraps Sale Plans, Flags Profit AheadApril 8, 2025 | marketwatch.comTissue Regenix Group Regulatory NewsFebruary 18, 2025 | lse.co.ukTissue Regenix Group Share Chat (TRX)November 3, 2024 | lse.co.ukSee More Headlines TRX Stock Analysis - Frequently Asked Questions How have TRX shares performed this year? Tissue Regenix Group's stock was trading at GBX 0.07 at the start of the year. Since then, TRX shares have increased by 0.0% and is now trading at GBX 0.07. How were Tissue Regenix Group's earnings last quarter? Tissue Regenix Group plc (LON:TRX) posted its quarterly earnings data on Wednesday, September, 2nd. The company reported ($0.16) earnings per share (EPS) for the quarter. Tissue Regenix Group had a negative net margin of 6.77% and a negative trailing twelve-month return on equity of 3.16%. How do I buy shares of Tissue Regenix Group? Shares of TRX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Tissue Regenix Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Tissue Regenix Group investors own include Lloyds Banking Group (LLOY), Argos Therapeutics (ARGSQ), FuelCell Energy (FCEL), TransEnterix (TRXDW), Swedbank (SWDBY), Trevena (TRVN) and Barrick Gold (ABX). Company Calendar Last Earnings9/02/2020Today6/23/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryPrecious Metals Current SymbolLON:TRX CIKN/A Webwww.tissueregenix.com Phone+44-1904-567609FaxN/AEmployees120Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (1.91) Trailing P/E RatioN/A Forward P/E Ratio0.14 P/E GrowthN/ANet Income-£1.11 million Net Margins-6.77% Pretax MarginN/A Return on Equity-3.16% Return on Assets0.50% Debt Debt-to-Equity Ratio37.46 Current Ratio2.88 Quick Ratio2.36 Sales & Book Value Annual Sales£27.75 million Price / Sales0.00 Cash FlowGBX 0.01 per share Price / Cash Flow5.70 Book ValueGBX 41.58 per share Price / Book0.00Miscellaneous Outstanding Shares71,235,000Free FloatN/AMarket Cap£51.65 thousand OptionableNot Optionable Beta1.61 5G Stocks: The Path Forward is ProfitableClick the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (LON:TRX) was last updated on 6/23/2026 by MarketBeat.com Staff. From Our PartnersThe 1934 playbookIn 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...American Alternative | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredThe roadshow starts Monday. This stock isn't ready.The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...Behind the Markets | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tissue Regenix Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Tissue Regenix Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
